Department of Chemical, Biochemical, and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA.
AAPS PharmSciTech. 2012 Dec;13(4):1473-82. doi: 10.1208/s12249-012-9875-3. Epub 2012 Oct 23.
Recent interest in the development of drug particle-laden strip-films suggests the need for establishing standard regulatory tests for their dissolution. In this work, we consider the dissolution testing of griseofulvin (GF) particles, a poorly water-soluble compound, incorporated into a strip-film dosage form. The basket apparatus (USP I) and the flow-through cell dissolution apparatus (USP IV) were employed using 0.54% sodium dodecyl sulfate as the dissolution medium as per USP standard. Different rotational speeds and dissolution volumes were tested for the basket method while different cell patterns/strip-film position and dissolution media flow rate were tested using the flow-through cell dissolution method. The USP I was not able to discriminate dissolution of GF particles with respect to particle size. On the other hand, in the USP IV, GF nanoparticles incorporated in strip-films exhibited enhancement in dissolution rates and dissolution extent compared with GF microparticles incorporated in strip-films. Within the range of patterns and flow rates used, the optimal discrimination behavior was obtained when the strip-film was layered between glass beads and a flow rate of 16 ml/min was used. These results demonstrate the superior discriminatory power of the USP IV and suggest that it could be employed as a testing device in the development of strip-films containing drug nanoparticles.
最近人们对载药条带薄膜的开发产生了兴趣,这表明有必要建立标准的监管测试方法来检测其溶解情况。在这项工作中,我们考虑了将难溶性化合物灰黄霉素(GF)颗粒包埋在条带薄膜剂型中的溶解测试。采用USP 标准中的 0.54%十二烷基硫酸钠作为溶解介质,使用篮法(USP I)和流通池溶出仪(USP IV)进行实验。篮法实验测试了不同的转速和溶解体积,而流通池溶出仪实验则测试了不同的池模式/条带薄膜位置和溶解介质流速。USP I 无法区分 GF 颗粒的溶解情况与颗粒大小有关。另一方面,在 USP IV 中,与包埋在条带薄膜中的 GF 微颗粒相比,包埋在条带薄膜中的 GF 纳米颗粒表现出了更高的溶解速率和溶解程度。在所使用的图案和流速范围内,当条带薄膜分层放置在玻璃珠之间且流速为 16ml/min 时,获得了最佳的区分效果。这些结果表明 USP IV 具有优越的区分能力,并建议将其用作含有药物纳米颗粒的条带薄膜开发的测试设备。